1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRothman Opioid Foundation Research Grants is sponsored by Rothman Opioid Foundation. Supports research on opioid-sparing pain management strategies and alternative therapies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Grants | Rothman Opioid The mission of the Rothman Opioid Foundation is to help combat the opioid crisis through education, research, and advocacy.
To achieve this mission, the Rothman Opioid Foundation is dedicated to support research around the opioid crisis; including and not limited to: Opioid-sparing or mitigating pain management strategies Social, psychological, and behavioral determinants of substance abuse Evaluations of alternative pain solutions, including medical cannabis and non-pharmacologic modalities.
The Research Grants function similarly to the NIH Small Research Grant Program (R03). The R03 grant mechanism supports small research projects that can be carried out in a short period of time with limited resources. Typical study scope can include, but is not limited to: Self-contained research projects Secondary analysis of existing data All grants are for up to $10,000 per year.
An academic or research professional with an academic appointment, specializing in the areas of opioid abuse, pain management, substance abuse, psychology, and public health. Alternatively, graduate students (ie, MPH, MBA, MS, or MA) or professional students and/or resident physicians (ie, MD or DO) are also eligible to apply, but with a faculty mentor meeting the academic credentials above.
Submit a research proposal with the following required elements: Principle Investigator (and Faculty Mentor, if applicable) Project Narrative (include background, hypothesis, methodology, and goals with study results) Proof of IRB (either IRB approval or proof of IRB application) Budget (with justifications) CV of Principle Investigator Support Letter from Faculty Mentor if Principle Investigator is a student.
Biosketches for additional Investigator(s), if applicable (one page per additional investigator) Submitted completed application packet electronically to: Lilly. Caso@rothmanopioid. org Applications are received and reviewed on a rolling basis.
Grants are for a one-year period, and can be renewed with a re-application. Grant funds are to be used only for “direct costs”, and not “indirect costs”. Grant funds are not to be used for travel or presentation.
Grant funds can be used to cover publication fees. Grant awardees will receive $5000 upon acceptance. The remaining $5000 will be submitted upon study completion and proof of journal submission for potential publication.
When presented and/or published, citation of the research funding is required with the notation as approximately: “The study was supported by the Rothman Opioid Foundation” Grant Submission Currently Closed Let’s Work Together Get in touch so we can start working together.
According to the current listing, eligibility includes: Researchers and institutions conducting studies on opioid alternatives and pain management. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Rothman Opioid Foundation Research Grants is funded by Rothman Opioid Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe FY2026 COPS Anti-Heroin Task Force program funds statewide opioid-interdiction task forces with awards up to $4 million and no local match. But eligibility is narrower than most agencies assume, and there are two deadlines — July 23 and July 29. Here's the deep dive on who qualifies and how to build a competitive application.
Read articleThe RCORP-Planning and RCORP-Impact programs offer $100K to $750K/year for rural communities fighting substance use disorder. Applications close May 29 and June 1. A strategic guide for first-time and returning applicants.
Read article